🟢 Inovio Pharmaceuticals is trading 6% up in after-hours trading; no verified company-specific catalyst reported

Inovio Pharmaceuticals is trading at $1.05, up 6.05% after hours; available reporting has not identified a verified company-specific catalyst.

• An October 16 report said AstraZeneca was trimming its collaboration to one vaccine, but attributed a pre-market decline—not this after-hours rise—to that news.
• The broader market was sharply lower, including the Nasdaq; available evidence does not establish that market sentiment explains the move.
• No after-hours volume or activity data was provided.